A study found that curcumin combined with (−)-epigallocatechin-3-gallate (EGCG) reduced tumor growth and angiogenesis by inhibiting the JAK/STAT3/IL-8 signaling pathway in CRC [115]. This evidence concerns the gene CXCL8 and colorectal carcinoma.